Compounded semaglutide at roughly $240 per month produces approximately 15% weight loss, working out to about $16 per month per percentage point of weight loss
Karger, 189-201, 2000
Its stepping in where the industrial model falls short: overpriced brand-name drugs, chronic shortages, rigid dose formulations, and one-size-fits-all products
Liraglutide suppresses postprandial triglyceride and apolipoprotein B48 elevations after a fat-rich meal in patients with type 2 diabetes: A randomized, double-blind, placebo-controlled, cross-over trial
PlexusDx annualized pricing at month-to-month rates: Microdose GLP-1 Protocol $1,548/year ($129/mo flat), Semaglutide Injection $2,268/year ($189/mo, or $1,788/year at $149/mo on the 6-month plan), Tirzepatide Injection $3,468/year ($289/mo, or $2,988/year at $249/mo on the 6-month plan), GLP-Squared $3,468/year ($289/mo)